Tag: life sciences
-
Grant Funds Implanted Brain-Computer Spinal Injury Device
A project to develop a brain-computer device to stimulate upper and lower limb movement in people with spinal cord injuries is receiving a €3.7 million award.
-
Biotech, Regeneron in $2B Cancer Antibody Deal
A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies.
-
Residual Cancer Detection Company Launches, Raises $56M
A start-up enterprise developing personalized liquid biopsies for finding residual cancer in patients is beginning work and raising $56 million in venture funds.
-
Company to Boost Orphan Drugs in Europe
A start-up enterprise seeks to make drugs for treating rare diseases more readily available to physicians and patients in Europe.
-
Biotech, M.D. Anderson Partner on Precision Drug Design
A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines.
-
Companies to Partner on Sustainable Synthetic Biochemicals
A producer of plant-based organic acids and a developer of synthetic bio-based materials and services are partnering on new sustainable industrial chemicals.
-
Neurons Identified, Stimulated for Spinal Cord Repair
Spinal cord injury patients in a clinical trial received electronic stimulation to a specified set of nerve cells that enabled them to restore walking after rehabilitation.
-
Patent Awarded for Focused Ultrasound Skin Treatments
A company developing non-invasive ultrasound treatments for treating skin disorders and removing tattoos received a patent for its technology.
-
Covid-19 Vaccine Patch Clinical Trial Begins
Developers of a patch with tiny needles instead of a syringe to deliver vaccines say a clinical trial testing a Covid-19 patch is now underway in Australia.
-
Trial Shows Results for Personal Cancer Immunotherapies
Interim results from a clinical trial testing personalized therapies invoking the immune system show responses from some patients with advanced liver cancer.